Ellen Rohde
Corporate Officer/Principal bei VERVE THERAPEUTICS, INC.
Profil
Ellen Rohde is currently the VP-Preclinical Pharmacology & Toxicology at Verve Therapeutics, Inc. She previously worked as an Associate Director at Biogen, Inc., Director-Analytical Chemistry & DMPK at Cerulean Pharma, Inc., and Senior Director-Pharmacokinetics at Intellia Therapeutics,.
Inc. Rohde holds a doctorate degree from the University of Cincinnati (Ohio) and a graduate degree from Universität Leipzig.
Aktive Positionen von Ellen Rohde
| Unternehmen | Position | Beginn |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2019 |
Ehemalige bekannte Positionen von Ellen Rohde
| Unternehmen | Position | Ende |
|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Ellen Rohde
| University of Cincinnati (Ohio) | Doctorate Degree |
| Universität Leipzig | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
